Real-World Study of Once-Daily, Extended-Release Tacrolimus Versus Twice-Daily, Immediate-Release Tacrolimus in Kidney Transplantation: Clinical Outcomes and Healthcare Resource Utilization
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1865-8652
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Real-World Study of Once-Daily, Extended-Release Tacrolimus Versus Twice-Daily, Immediate-Release Tacrolimus in Kidney Transplantation: Clinical Outcomes and Healthcare Resource Utilization ; day:2 ; month:4 ; year:2019 ; pages:1-15
Advances in therapy ; (2.4.2019), 1-15
- Creator
-
Ho, Bing
Bhagat, Hardik
Schwartz, Jason J.
Atiemo, Kofi
Daud, Amna
Kang, Raymond
Montag, Samantha E.
Zhao, Lihui
Lee, Edward
Skaro, Anton I.
Ladner, Daniela P.
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1007/s12325-019-00904-x
- URN
-
urn:nbn:de:101:1-2019042312422230765509
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 10:59 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Ho, Bing
- Bhagat, Hardik
- Schwartz, Jason J.
- Atiemo, Kofi
- Daud, Amna
- Kang, Raymond
- Montag, Samantha E.
- Zhao, Lihui
- Lee, Edward
- Skaro, Anton I.
- Ladner, Daniela P.
- SpringerLink (Online service)
Other Objects (12)
A prospective cohort conversion study of twice-daily to once-daily extended-release tacrolimus: role of ethnicity
Effects of Renal Impairment on the Pharmacokinetics of Once-Daily Amantadine Extended-Release Tablets
Renal function and patient-reported outcomes in stable kidney transplant patients following conversion from twice-daily immediate-release tacrolimus to once-daily prolonged-release tacrolimus: a 12-month observational study in routine clinical practice in Germany (ADAGIO)
Hat die Metabolisierungsrate von extended-release Tacrolimus einen Einfluss auf die Nierenfunktion nach Nierentransplantation?
Increased renal function decline in fast metabolizers using extended-release tacrolimus after kidney transplantation
Once-Daily versus Twice-Daily Tacrolimus in Kidney Transplantation: A Systematic Review and Meta-analysis of Observational Studies
Pharmacokinetics of Prolonged-Release Once-Daily Formulations of Tacrolimus in De Novo Kidney Transplant Recipients: A Randomized, Parallel-Group, Open-Label, Multicenter Study
Effects of CYP3A5 polymorphism on the pharmacokinetics of a once-daily modified-release tacrolimus formulation and acute kidney injury in hematopoietic stem cell transplantation
Correction to: Once-Daily versus Twice Daily Tacrolimus in Kidney Transplantation: A Systematic Review and Meta-analysis of Observational Studies
Conversion of liver transplant recipients from twice-daily to novel once-daily Tacrolimus: a 2-year prospective study on adherence, safety, and efficacy
Comparison of once-daily versus twice-daily combination of Ropinirole prolonged release in Parkinson’s disease
Evaluating the Cost-Effectiveness of Prolonged-Release Tacrolimus Relative to Immediate-Release Tacrolimus in Liver Transplant Patients Based on Data from Routine Clinical Practice
A prospective cohort conversion study of twice-daily to once-daily extended-release tacrolimus: role of ethnicity
Effects of Renal Impairment on the Pharmacokinetics of Once-Daily Amantadine Extended-Release Tablets
Renal function and patient-reported outcomes in stable kidney transplant patients following conversion from twice-daily immediate-release tacrolimus to once-daily prolonged-release tacrolimus: a 12-month observational study in routine clinical practice in Germany (ADAGIO)
Hat die Metabolisierungsrate von extended-release Tacrolimus einen Einfluss auf die Nierenfunktion nach Nierentransplantation?
Increased renal function decline in fast metabolizers using extended-release tacrolimus after kidney transplantation
Once-Daily versus Twice-Daily Tacrolimus in Kidney Transplantation: A Systematic Review and Meta-analysis of Observational Studies
Pharmacokinetics of Prolonged-Release Once-Daily Formulations of Tacrolimus in De Novo Kidney Transplant Recipients: A Randomized, Parallel-Group, Open-Label, Multicenter Study
Effects of CYP3A5 polymorphism on the pharmacokinetics of a once-daily modified-release tacrolimus formulation and acute kidney injury in hematopoietic stem cell transplantation
Correction to: Once-Daily versus Twice Daily Tacrolimus in Kidney Transplantation: A Systematic Review and Meta-analysis of Observational Studies
Conversion of liver transplant recipients from twice-daily to novel once-daily Tacrolimus: a 2-year prospective study on adherence, safety, and efficacy
Comparison of once-daily versus twice-daily combination of Ropinirole prolonged release in Parkinson’s disease
Evaluating the Cost-Effectiveness of Prolonged-Release Tacrolimus Relative to Immediate-Release Tacrolimus in Liver Transplant Patients Based on Data from Routine Clinical Practice
A prospective cohort conversion study of twice-daily to once-daily extended-release tacrolimus: role of ethnicity
Effects of Renal Impairment on the Pharmacokinetics of Once-Daily Amantadine Extended-Release Tablets
Renal function and patient-reported outcomes in stable kidney transplant patients following conversion from twice-daily immediate-release tacrolimus to once-daily prolonged-release tacrolimus: a 12-month observational study in routine clinical practice in Germany (ADAGIO)
Hat die Metabolisierungsrate von extended-release Tacrolimus einen Einfluss auf die Nierenfunktion nach Nierentransplantation?
Increased renal function decline in fast metabolizers using extended-release tacrolimus after kidney transplantation
Once-Daily versus Twice-Daily Tacrolimus in Kidney Transplantation: A Systematic Review and Meta-analysis of Observational Studies
Pharmacokinetics of Prolonged-Release Once-Daily Formulations of Tacrolimus in De Novo Kidney Transplant Recipients: A Randomized, Parallel-Group, Open-Label, Multicenter Study
Effects of CYP3A5 polymorphism on the pharmacokinetics of a once-daily modified-release tacrolimus formulation and acute kidney injury in hematopoietic stem cell transplantation
Correction to: Once-Daily versus Twice Daily Tacrolimus in Kidney Transplantation: A Systematic Review and Meta-analysis of Observational Studies
Conversion of liver transplant recipients from twice-daily to novel once-daily Tacrolimus: a 2-year prospective study on adherence, safety, and efficacy
Comparison of once-daily versus twice-daily combination of Ropinirole prolonged release in Parkinson’s disease